tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kerry Holford, 11 are a HOLD (61.11%), 7 are a BUY (38.89%).
Analyst Kerry Holford, currently employed at BERENBERG, carries an average stock price target met ratio of 76.19% that have a potential upside of 14.29% achieved within 197 days.
Kerry Holford’s has documented 32 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 02-Dec-2024.
Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 10/11/2021. The price target of $270 was fulfilled within 66 days with a profit of $44.3 (19.63%) receiving and performance score of 2.97.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$41
$-0.03 (-0.07%)
6 months ago
(02-Dec-2024)
1/1 (100%)
$6.69 (19.50%)
179
Hold
$53
6 months 21 days ago
(12-Nov-2024)
2/4 (50%)
$15.58 (41.64%)
379
Buy
10 months 1 days ago
(01-Aug-2024)
1/13 (7.69%)
$-10.5 (-32.65%)
64
Buy
$45
$3.97 (9.68%)
$47
10 months 17 days ago
(16-Jul-2024)
1/3 (33.33%)
$6.9 (18.11%)
2259
Buy
$19.52
1 years 3 months 20 days ago
(13-Feb-2024)
0/3 (0%)
$-13.88 (-41.56%)
What Year was the first public recommendation made by Kerry Holford?
